{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:23:20Z","timestamp":1791501800687,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"am","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jaut.2024.103220","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T03:09:01Z","timestamp":1713496141000},"page":"103220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7823-1827","authenticated-orcid":false,"given":"Kevin","family":"Chevalier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Chassagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Leonard-Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Dunogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Regent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Thoreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Chaigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2024.103220_bib1","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jaut.2024.103220_bib2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103220_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-018-8718-8","article-title":"Antinuclear antibodies in systemic sclerosis: an update","volume":"58","author":"Stochmal","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2024.103220_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152156","article-title":"Isolated sicca syndrome and scleroderma-specific autoantibodies: sj\u00f6gren\u2019s syndrome or early Systemic Sclerosis localized in salivary glands?","volume":"58","author":"Marketos","year":"2023","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103220_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103220_bib6","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00296-018-4059-4","article-title":"The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease","volume":"38","author":"Dima","year":"2018","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2024.103220_bib7","doi-asserted-by":"crossref","first-page":"A106","DOI":"10.1016\/j.revmed.2021.03.040","article-title":"Significations cliniques des anticorps anti-RNP au cours du lupus \u00e9ryth\u00e9mateux syst\u00e9mique","volume":"42","author":"Ben Brahim","year":"2021","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.jaut.2024.103220_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00296-022-05161-w","article-title":"The diagnostic challenge of patients with anti-U1-RNP antibodies","volume":"43","author":"Elhani","year":"2022","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2024.103220_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001033","article-title":"Anti-RNP positivity in primary Sj\u00f6gren\u2019s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement","volume":"5","author":"Abbara","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.jaut.2024.103220_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102465","article-title":"Anti-RNP antibodies delineate a subgroup of myositis: a systematic retrospective study on 46 patients","volume":"19","author":"Wesner","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103220_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2249.1999.00961.x","article-title":"Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis","volume":"117","author":"Ihn","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2024.103220_bib12","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/art.34482","article-title":"A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis","volume":"64","author":"Steen","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103220_bib13","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00296-013-2668-5","article-title":"Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients","volume":"33","author":"Poormoghim","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2024.103220_bib14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/art.39432","article-title":"Characteristics and survival of anti-U1 RNP antibody-positive patients with connective tissue disease-associated pulmonary arterial hypertension: anti-U1 RNP antibodies in ctd-associated PAH","volume":"68","author":"Sobanski","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103220_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13075-020-2113-6","article-title":"Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis","volume":"22","author":"Ledoult","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2024.103220_bib16","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/joim.13752","article-title":"Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: a multicenter retrospective cohort","volume":"295","author":"Chevalier","year":"2023","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jaut.2024.103220_bib17","series-title":"Diagnostic Criteria for Classification of MCTD. Mixed Connective Tissue Disease and Antinuclear Antibodies","first-page":"23","author":"Sharp","year":"1987"},{"key":"10.1016\/j.jaut.2024.103220_bib18","series-title":"Mixed Connective Tissue Disease and Anti-nuclear Antibodies","first-page":"33","article-title":"Classification and diagnostic criteria for mixed connective tissue disease","author":"Anon Alarcon-Segovia","year":"1987"},{"key":"10.1016\/j.jaut.2024.103220_bib19","series-title":"Les Maladies Syst\u00e9miques","first-page":"545","article-title":"Syndrome de Sharp","author":"Anon","year":"1991"},{"key":"10.1016\/j.jaut.2024.103220_bib20","series-title":"Mixed Connective Tissue Disease and Anti-nuclear Antibodies","first-page":"41","article-title":"Preliminary diagnostic criteria for classification of mixed connective tissue disease","author":"Anon Kasukawa","year":"1987"},{"key":"10.1016\/j.jaut.2024.103220_bib21","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103220_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/art.1780400928","article-title":"Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103220_bib23","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative: ACR\/EULAR classification criteria for SSc","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103220_bib24","doi-asserted-by":"crossref","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria","volume":"51","author":"Kay","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103220_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jaut.2024.103220_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"American college of rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data\u2010driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103220_bib27","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/art.40809","article-title":"Generation of a core set of items to develop classification criteria for scleroderma renal crisis using consensus methodology","volume":"71","author":"Butler","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103220_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103261","article-title":"Systemic sclerosis associated myopathy","volume":"22","author":"Chaigne","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103220_bib29","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jaut.2024.103220_bib30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13023-021-01844-y","article-title":"French recommendations for the management of systemic sclerosis","volume":"16","author":"Hachulla","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jaut.2024.103220_bib31","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103220_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccm.2019.05.001","article-title":"Pulmonary manifestations of systemic sclerosis and mixed connective tissue disease","volume":"40","author":"Perelas","year":"2019","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.jaut.2024.103220_bib33","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.3899\/jrheum.210533","article-title":"Esophageal dilation and other clinical factors associated with pulmonary function decline in patients with systemic sclerosis","volume":"48","author":"Showalter","year":"2021","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103220_bib34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2013-204487","article-title":"Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis","volume":"74","author":"Moinzadeh","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103220_bib35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/kel252","article-title":"Sjogren's syndrome is associated with and not secondary to systemic sclerosis","volume":"46","author":"Salliot","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103220_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13256-022-03727-7","article-title":"Glomerulonephritis associated with systemic sclerosis: a case report","volume":"17","author":"Nayebirad","year":"2023","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.jaut.2024.103220_bib37","first-page":"1123","article-title":"Kidney involvement in systemic sclerosis","volume":"12","author":"Reggiani","year":"2022","journal-title":"J. Phys. Math."},{"key":"10.1016\/j.jaut.2024.103220_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.2006.066985","article-title":"Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients","volume":"67","author":"Teixeira","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103220_bib39","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/rheumatology\/ker271","article-title":"Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls","volume":"51","author":"Guillevin","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103220_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/2324709617734012","article-title":"Scleroderma renal crisis in mixed connective tissue disease with full renal recovery within 3 Months: a case report with expanding treatment modalities to treat each clinical sign as an independent entity","volume":"5","author":"Cheta","year":"2017","journal-title":"Journal of Investigative Medicine High Impact Case Reports"},{"key":"10.1016\/j.jaut.2024.103220_bib41","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s10067-006-0442-8","article-title":"Mixed connective tissue disease: a case with scleroderma renal crisis following abortion","volume":"26","author":"Celikbilek","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103220_bib42","first-page":"1","article-title":"Scleroderma renal crisis in a case of mixed connective tissue disease treated successfully with angiotensin-converting enzyme inhibitors","author":"Madieh","year":"2021"},{"key":"10.1016\/j.jaut.2024.103220_bib43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rdc.2005.04.011","article-title":"Other manifestations of mixed connective tissue disease","volume":"31","author":"Pope","year":"2005","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.jaut.2024.103220_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.berh.2016.03.002","article-title":"Mixed connective tissue disease","volume":"30","author":"Gunnarsson","year":"2016","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103220_bib45","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2024.103220_bib46","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103220_bib47","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/ard.2008.095919","article-title":"A descriptive and prognostic study of systemic sclerosis-associated myopathies","volume":"68","author":"Ranque","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103220_bib48","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/acr.23291","article-title":"Association of fibrosing myopathy in systemic sclerosis and higher mortality","volume":"69","author":"Paik","year":"2017","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2024.103220_bib49","doi-asserted-by":"crossref","first-page":"SI82","DOI":"10.1093\/rheumatology\/keac361","article-title":"Clinico\u2013pathological phenotypes of systemic sclerosis\u2013associated myopathy: analysis of a large multicentre cohort","volume":"62","author":"Matas-Garc\u00eda","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103220_bib50","doi-asserted-by":"crossref","first-page":"A311","DOI":"10.1016\/j.autrev.2009.11.003","article-title":"Geoepidemiology of systemic sclerosis","volume":"9","author":"Ranque","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103220_bib51","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103220_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12931-019-0980-7","article-title":"Interstitial lung disease associated with systemic sclerosis (SSc-ILD)","volume":"20","author":"Cottin","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.jaut.2024.103220_bib53","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1164\/rccm.201903-0486OC","article-title":"Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort","volume":"200","author":"Hoffmann-Vold","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2024.103220_bib54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/annrheumdis-2020-217455","article-title":"Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database","volume":"80","author":"Hoffmann-Vold","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103220_bib55","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/art.39166","article-title":"Predictive value of serial high\u2010resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis","volume":"67","author":"Hoffmann\u2010Vold","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103220_bib56","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2024.103220_bib57","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.40130","article-title":"Short\u2010term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis","volume":"69","author":"Goh","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103220_bib58","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1513\/AnnalsATS.201806-362OC","article-title":"Does systemic sclerosis\u2013associated interstitial lung disease burn out? Specific phenotypes of disease progression","volume":"15","author":"Guler","year":"2018","journal-title":"Annals ATS"},{"key":"10.1016\/j.jaut.2024.103220_bib59","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/rheumatology\/kev016","article-title":"Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modelling","volume":"54","author":"Man","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103220_bib60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/RHU.0000000000001127","article-title":"Characterization of interstitial lung disease associated with anti-ribonucleoprotein antibodies","volume":"26","author":"Lhote","year":"2020","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103220_bib61","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar3763","article-title":"Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis","volume":"14","author":"Hudson","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2024.103220_bib62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/kev300","article-title":"Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease","volume":"55","author":"Gunnarsson","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103220_bib63","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103220_bib64","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103220_bib65","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-019-1867-1","article-title":"Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature","volume":"21","author":"Pokeerbux","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2024.103220_bib66","article-title":"Authors reply: clinical presentation, course, and prognosis of patients with mixed connective tissue disease","author":"Chevalier","year":"2024","journal-title":"J. Intern. Med."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T23:56:46Z","timestamp":1717631806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":66,"alternative-id":["S0896841124000544"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103220","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103220"}}